Walden R J, Hernandez R, Witts D, Graham B R, Prichard B N
Eur J Clin Pharmacol. 1981;20(1):53-8. doi: 10.1007/BF00554667.
Single oral doses of hydralazine (Apresoline) 50 mg were administered on two occasions to eight healthy volunteers when fed and fasting. Blood and saliva samples were taken at intervals after dosing and analysed for drug. Heart rate and blood pressure were measured before and at intervals after dosing, at rest, after tilt and exercise. Plasma hydralazine levels showed wide inter-individual variation. The areas under the plasma concentration-time curve (0-8 h), the height of the peak plasma levels and the time to peak were not significantly different between the fed and fasting state. Salivary hydralazine levels were readily measurable but showed little correlation with plasma levels. The heart rate and pulse pressure were increased after drug both at rest, supine and erect, and after exercise for between 6 and 8 h.
在进食和空腹状态下,对8名健康志愿者分两次给予单剂量口服50毫克肼屈嗪(阿普利素灵)。给药后定期采集血液和唾液样本并进行药物分析。在给药前、给药后定期、静息时、倾斜后和运动后测量心率和血压。血浆肼屈嗪水平显示出较大的个体间差异。进食和空腹状态下,血浆浓度-时间曲线下面积(0至8小时)、血浆峰值水平高度和达峰时间无显著差异。唾液中的肼屈嗪水平易于测量,但与血浆水平几乎没有相关性。服药后,无论是静息时、仰卧位和直立位,还是运动后6至8小时内,心率和脉压均升高。